June 28, 2016
Press Call to Explore NIH Patent Policies Compromising Medicine Affordability, the Agency’s Transparency, More
Knowledge Ecology International, Public Citizen, Universities Allied for Essential Medicines to Participate
WHAT: Conference call to discuss the negative consequences of the National Institutes of Health’s (NIH) intellectual property policies for medicine affordability and access, including its recent refusal to authorize generic competition for Xtandi, as well as the grant of exclusive licenses on NIH-patented inventions and transparency of decision-making at NIH. In particular, participants will discuss Knowledge Ecology International’s petition for the NIH to use its march-in rights or royalty-free license on the patents on Xtandi. They also will discuss NIH policy in regard to the grant of exclusive licenses on government-owned inventions, and transparency.
WHO: James Love, executive director, Knowledge Ecology International
Andrew S. Goldman, counsel for policy and legal affairs, Knowledge Ecology International
Diane Singhroy, scientific and technical advisor, Knowledge Ecology International
Peter Maybarduk, director, Public Citizen’s Access to Medicines program
Merith Basey, executive director, Universities Allied for Essential Medicines
Rachel Sachs, academic, Harvard University
Aaron Kesselheim, academic, Harvard University
Mickey Davis, academic, Cleveland State University
WHEN: 11 a.m. EDT Wednesday, June 29
CALL-IN NUMBER: To get the number, please contact Zack Struver, email@example.com, (202) 332-2670 or (914) 582-1428.